IL145867A0 - Pharmaceutical compositions containing 6(5h)-phenanthridinone derivatives - Google Patents

Pharmaceutical compositions containing 6(5h)-phenanthridinone derivatives

Info

Publication number
IL145867A0
IL145867A0 IL14586700A IL14586700A IL145867A0 IL 145867 A0 IL145867 A0 IL 145867A0 IL 14586700 A IL14586700 A IL 14586700A IL 14586700 A IL14586700 A IL 14586700A IL 145867 A0 IL145867 A0 IL 145867A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
phenanthridinone
derivatives
phenanthridinone derivatives
Prior art date
Application number
IL14586700A
Other languages
English (en)
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of IL145867A0 publication Critical patent/IL145867A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/473Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/10Aza-phenanthrenes
    • C07D221/12Phenanthridines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL14586700A 1999-04-19 2000-04-19 Pharmaceutical compositions containing 6(5h)-phenanthridinone derivatives IL145867A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11076699 1999-04-19
PCT/JP2000/002534 WO2000063179A1 (fr) 1999-04-19 2000-04-19 Potentialisateurs de la neurotrophine

Publications (1)

Publication Number Publication Date
IL145867A0 true IL145867A0 (en) 2002-07-25

Family

ID=14544047

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14586700A IL145867A0 (en) 1999-04-19 2000-04-19 Pharmaceutical compositions containing 6(5h)-phenanthridinone derivatives

Country Status (18)

Country Link
US (1) US20020119993A1 (xx)
EP (1) EP1172360A4 (xx)
JP (1) JP2001002572A (xx)
KR (1) KR20010112441A (xx)
CN (1) CN1356984A (xx)
AU (1) AU3839200A (xx)
BR (1) BR0009846A (xx)
CA (1) CA2370721A1 (xx)
CZ (1) CZ20013584A3 (xx)
HK (1) HK1039941A1 (xx)
HU (1) HUP0200866A3 (xx)
ID (1) ID30307A (xx)
IL (1) IL145867A0 (xx)
NO (1) NO20015060L (xx)
PL (1) PL351383A1 (xx)
TR (1) TR200103042T2 (xx)
WO (1) WO2000063179A1 (xx)
ZA (1) ZA200108419B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2330350A1 (en) 2000-12-05 2002-06-05 Chemokine Therapeutics Corporation Therapeutics for chemokine mediated diseases
AU2002215737A1 (en) * 2000-12-05 2002-06-18 Chemokine Therapeutics Corporation Tricyclic therapeutics for chemokine mediated diseases
CN102944674B (zh) * 2012-11-05 2014-10-22 武汉远征世纪制药有限公司 一种检测TrkB受体pan-Tyr位点活性的ELISA试剂盒及其使用方法
CN107082761B (zh) * 2017-04-17 2020-04-03 上海大学 菲啶酮或苯并菲啶酮衍生物及其合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID18046A (id) * 1996-08-20 1998-02-19 Takeda Chemical Industries Ltd Senyawa siklik campuran, pembuatan dan penngunaannya.
US20020022636A1 (en) * 1997-09-03 2002-02-21 Jia-He Li Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
WO1999011644A1 (en) * 1997-09-03 1999-03-11 Guilford Pharmaceuticals Inc. Di-n-heterocyclic compounds, methods, and compositions for inhibiting parp activity

Also Published As

Publication number Publication date
BR0009846A (pt) 2002-02-13
HUP0200866A2 (hu) 2002-07-29
EP1172360A1 (en) 2002-01-16
NO20015060D0 (no) 2001-10-18
KR20010112441A (ko) 2001-12-20
TR200103042T2 (tr) 2002-03-21
NO20015060L (no) 2001-12-18
CN1356984A (zh) 2002-07-03
US20020119993A1 (en) 2002-08-29
CZ20013584A3 (cs) 2002-03-13
JP2001002572A (ja) 2001-01-09
HUP0200866A3 (en) 2003-02-28
PL351383A1 (en) 2003-04-07
ID30307A (id) 2001-11-22
AU3839200A (en) 2000-11-02
WO2000063179A1 (fr) 2000-10-26
EP1172360A4 (en) 2004-02-04
ZA200108419B (en) 2003-03-26
CA2370721A1 (en) 2000-10-26
HK1039941A1 (zh) 2002-05-17

Similar Documents

Publication Publication Date Title
ZA986889B (en) Controlled release pharmaceutical compositions containing tiagabine
HUP0203378A3 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
IL149421A0 (en) Pharmaceutical compositions containing fed mode inducing agents
NZ304982A (en) Pyridinyloxy- or pyridinylamino-acetamide derivatives; pharmaceutical compositions
HUP0202513A3 (en) Betha-carboline pharmaceutical compositions
HUP0100867A3 (en) Pharmaceutical compositions containing celecoxib
HUP0103256A3 (en) Thiobenzimidazole derivatives and pharmaceutical compositions containing the compounds
GB0028088D0 (en) Pharmaceutical compositions
GB0001662D0 (en) Pharmaceutical compositions
IL146434A0 (en) Pharmaceutical compositions containing ecteinascidin 743
IL155067A0 (en) (dihydro) isoquinoline derivatives and pharmaceutical compositions containing the same
GB9923436D0 (en) Pharmaceutical compositions
HUP0202255A2 (en) Crystalline 1-methylcarbapenem compounds and pharmaceutical compositions containing them
HUP0000137A3 (en) Controller-release pharmaceutical composition containing anangetics
GB9809213D0 (en) Pharmaceutical compositions
HUP0200747A3 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
GB9904163D0 (en) Pharmaceutical compositions
IL148691A0 (en) Pharmaceutical compositions containing ciclesonide
GB2363572B (en) Pharmaceutical composition containing cyclosporin
IL142534A0 (en) Pharmaceutical compositions containing an antigen-adjuvent
ZA9710919B (en) Pharmaceutical compositions containing N-sulphony-lindole derivatives
GB9911017D0 (en) Pharmaceutical compositions
IL148725A0 (en) Aqueous pharmaceutical compositions containing circlesonide
HUP0001308A3 (en) (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents, process for their preparation and pharmaceutical compositions containing the same
IL145867A0 (en) Pharmaceutical compositions containing 6(5h)-phenanthridinone derivatives